Interchange Capital Partners LLC Cuts Stake in Danaher Corporation $DHR

Interchange Capital Partners LLC reduced its position in Danaher Corporation (NYSE:DHR) by 12.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,700 shares of the conglomerate’s stock after selling 239 shares during the quarter. Interchange Capital Partners LLC’s holdings in Danaher were worth $336,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. MGO One Seven LLC grew its holdings in Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Chicago Capital LLC lifted its stake in shares of Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after buying an additional 1,391 shares during the period. UniSuper Management Pty Ltd lifted its stake in shares of Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after buying an additional 2,667 shares during the period. Asahi Life Asset Management CO. LTD. acquired a new stake in shares of Danaher during the first quarter worth $539,000. Finally, Horizon Financial Services LLC lifted its stake in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after buying an additional 8,160 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.20% of the company’s stock.

Danaher Trading Up 0.1%

NYSE DHR opened at $223.03 on Monday. The company has a market capitalization of $157.54 billion, a PE ratio of 45.99, a P/E/G ratio of 3.41 and a beta of 0.77. The company has a fifty day moving average of $202.73 and a 200 day moving average of $198.57. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm posted $1.71 earnings per share. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is presently 26.39%.

Analyst Upgrades and Downgrades

DHR has been the subject of several research reports. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a research note on Thursday. Guggenheim reiterated a “buy” rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. TD Cowen lifted their price objective on shares of Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.